BIODESIX INC (BDSX) Stock News

USA - NASDAQ:BDSX - US09075X1081 - Common Stock

6.42 USD

-0.53 (-7.63%)

Last: 10/17/2025, 5:01:00 PM

6.52 USD

+0.1 (+1.56%)

After Hours: 10/17/2025, 5:01:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BDSX Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Biodesix, Inc.

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting

2 days ago - By: Biodesix, Inc.

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting

11 days ago - By: Biodesix, Inc.

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit

11 days ago - By: Biodesix, Inc.

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit

2 months ago - By: Benzinga - Mentions: GSAT PGY ADV REAL ...

Earnings Scheduled For August 7, 2025

25 days ago - By: Benzinga - Mentions: GRI BRTX ONCO MBX ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

a month ago - By: Biodesix, Inc.

Biodesix Announces One-for-Twenty Reverse Stock Split

a month ago - By: Biodesix, Inc.

Biodesix Announces One-for-Twenty Reverse Stock Split

a month ago - By: Biodesix, Inc.

Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference

a month ago - By: Biodesix, Inc.

Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference

2 months ago - By: Biodesix, Inc.

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics

2 months ago - By: Biodesix, Inc.

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics

2 months ago - By: Zacks Investment Research - Mentions: HQY

Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates

2 months ago - By: Biodesix, Inc.

Biodesix Announces Second Quarter 2025 Results and Highlights

2 months ago - By: Biodesix, Inc.

Biodesix Announces Second Quarter 2025 Results and Highlights

2 months ago - By: Biodesix, Inc.

Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference

2 months ago - By: Biodesix, Inc.

Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference

3 months ago - By: Zacks Investment Research - Mentions: AVTR

Avantor, Inc. (AVTR) Q2 Earnings Lag Estimates

3 months ago - By: Biodesix, Inc.

Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025

3 months ago - By: Biodesix, Inc.

Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025

4 months ago - By: Biodesix, Inc.

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs

4 months ago - By: Biodesix, Inc.

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs

5 months ago - By: Biodesix, Inc.

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting